Tower Research Capital (TRC) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$303M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$59.2M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$17.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$14.7M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$12.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$26.8M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$24.6M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$24.2M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$24M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 3.47% |
| 2 | Industrials | 2.67% |
| 3 | Technology | 2.45% |
| 4 | Consumer Discretionary | 2.4% |
| 5 | Materials | 2.33% |
Similar funds
Tower Research Capital (TRC)'s Q3 2016 Portfolio in Review
As of Q3 2016, Tower Research Capital (TRC) held 5,392 positions worth $1.01B, down 3.8% from $1.05B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Tower Research Capital (TRC) withdrew a net $81.7M in Q3 2016, closing 1,628 positions and reducing 1,635 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 3.5% of assets, down from 6.2% a quarter earlier, followed by Industrials and Technology.
Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $14.7M.
- Tower Research Capital (TRC)'s largest Q3 2016 buy was Vanguard S&P 500 ETF: 74,203 shares worth $14.7M.
- Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $303M increase.
- Tower Research Capital (TRC)'s biggest Q3 2016 reduction was State Street Consumer Discretionary Select Sector SPDR ETF, cutting an estimated $24.2M.
- Tower Research Capital (TRC) fully exited iShares Biotechnology ETF in Q3 2016, selling an estimated $26.8M.
- Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $1.01B portfolio in Q3 2016.
- Tower Research Capital (TRC) opened 831 new positions and closed 1,628 in Q3 2016.
- Tower Research Capital (TRC)'s portfolio value fell 3.8% quarter-over-quarter to $1.01B.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2016, filed 8 Nov 2016.